These findings suggest that the spread of the highly resistant triple mutant dhps allele along with triple/quadruple mutant dhfr alleles in different parts of Africa could further compromise the effectiveness of SP for the treatment of falciparum malaria and may have implications for IPTp. The gene discussed is DHFR; the disease is Plasmodium falciparum malaria.